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Rapid conversion of highly porous borate glass
microspheres into hydroxyapatite†
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This paper reports on the rapid development of porous hydroxyapatite (HA) microspheres with large
external pores and fully interconnected porosity. These porous microspheres were produced by convert-
ing borates glasses (namely 45B5, B53P4 and 13-93B) into HA by immersing them in potassium phos-
phate media and simulated body fluid (SBF). Solid (SGMS) non-porous and highly porous (PGMS) micro-
spheres were prepared from borate glasses via a novel flame spheroidisation process and their physico-
chemical properties including in vitro biological response were investigated. Morphological and physical
characterisation of the PGMS showed interconnected porosity (up to 75 ± 5%) with average external pore
sizes of 50 ± 5 µm. Mass loss, ion release, X-ray diffraction (XRD) and Scanning electron microscopy
(SEM) analysis confirmed complete conversion to HA in 0.02 M K2HPO4 solution for the PGMS (with
exception of 13-93B glass) and at significantly faster rates compared to their SGMS counterparts.
However, 13-93B microspheres only converted to HA in Na2HPO4 solution. The in vitro SBF bioactivity
studies for all the borate compositions showed HA formation and much earlier for PGMS compared to
SGMS. Direct cell culture studies using hMSCs revealed that the converted porous HA microspheres
showed enhanced pro-osteogenic properties compared to their unconverted counterparts and such are
considered as highly promising candidate materials for bone repair (and orthobiological) applications.
1. Introduction
Hydroxyapatite, [Ca10(PO4)6(OH)2], is one of the most stable
forms of biological apatite and the major inorganic constitu-
ent of bone.1,2 Around 60–70% of bone tissue and 90% of
tooth enamel is made up of hydroxyapatite.3 It has been exten-
sively used clinically as a bone graft substitute for bone aug-
mentation, as an orthopaedic and dental implant coating4 and
has even been explored for drug delivery applications.5–7
Microspheres have some key advantages for use in bio-
medical applications over other particle geometries. For
example, delivery of microspheres to specific target sites via
simple injection procedures can be better facilitated due to
their enhanced flow properties.8 Moreover, porous microspheres
can be even more advantageous over solid (non-porous) micro-
spheres as they provide higher surface areas. They also exhibit
lower mass density, have shown superior cell attachment/pro-
liferation and are well suited for drug adsorption/absorption as
they can exhibit controlled drug release kinetics.9
To prepare porous hydroxyapatite (HA), several methods
have been developed such as template-assisted processes
which utilise hard templates (e.g. silica and carbon spheres10)
and soft templates (e.g. emulsion droplets,11 micelles12 and
gas bubbles13). Other methods have included hydrothermal
synthesis,14 self-assembly via solvothermal methods15 and by
spraying and freezing emulsions.16 For example, Zhang et al.14
fabricated HA microspheres (∼7–9 µm) and microflowers
(∼10 µm) via the hydrothermal synthesis method using
hexadecyltrimethylammonium bromide (CTAB) as a surfac-
tant. Ma et al.17 prepared hollow HA microspheres (∼3.6 µm)
consisting of nanorods using potassium sodium tartrate as a
chelating agent in water/N,N-dimethylformamide mixed sol-
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vents. Li et al.15 also prepared flower-like HA microspheres
which were self-assembled using nanosheets via solvothermal
treatment of calcined eggshells in hydrogen peroxide/N,N-di-
methylformamide. Whilst Xiao et al.16 prepared hollow and
porous HA microspheres (∼20 μm in diameter with pore sizes
∼0.6 μm) using an oil in water (O/W) emulsion spray freezing
method. Most of the methods stated above required 2–7 days
to obtain porous HA microspheres.
Borate-based glasses have recently received much interest
due to their successful application in wound healing.18
However, prior to this they had been shown to undergo conver-
sion to hydroxyapatite.19–24 Prof. Day and his research group
explored the HA formation on a borate glass termed 45S5B1,
which had the same composition as 45S5 but with all of the
SiO2 replaced with B2O3. They found that not only did HA
form on the surface of borate glass after immersion in K2HPO4
solution at 37 °C 25,26 it also formed more rapidly when com-
pared to silicate glass (45S5). Furthermore, in vivo studies
reported that 45S5B1 glass particles (which had been partially
converted into HA in K2HPO4 solution) formed bone tissue
more rapidly in comparison to 45S5 glass particles when
implanted within tibial defects in rats.25 Other in vivo studies
also showed that borate-based glass (e.g. 13-93B) scaffolds were
able to regrow bone in a rat subcutaneous implantation model
with no toxicity.27–29
There are only a few studies on the development of porous
microspheres from borate-based glass materials. For example,
Fu et al.30 prepared hollow HA microspheres with pore size of
∼13 nm by reacting solid microspheres of Li2O–CaO–B2O3
glass (size range 106–150 μm) in K2HPO4 solution. Amorphous
dysprosium lithium–borate glass microspheres (wt% compo-
sition 30% Dy2O3, 8.8% Li2O and 61.2% B2O3) developed pore
sizes of ∼30 nm after reaction with 0.25 M K2HPO4 solution at
37 °C.31 Flower-like porous magnesium borate (Mg3B2O6)
microspheres with diameters between 0.6–1.0 μm and pore
sizes ranging between 2–100 nm were synthesised using polyvi-
nyl pyrrolidone as a template.32
Most studies fabricating porous HA microspheres have
either used template-supports, structure-directing reagents,
and/or harmful organic solvents. Moreover, these processes
resulted in only achieving mesopores (ranging from 4 nm to
0.6 µm) which would not be suitable for cell incorporation.
Likewise, studies on borate-based glass microspheres have
similar drawbacks as they have only been reported to achieve
pore sizes ranging between 2 and 100 nm. Therefore, the devel-
opment of a rapid, effective and template-free method to
prepare highly porous HA microspheres with pore sizes
capable of supporting cell incorporation is an ongoing and
challenging process.
This paper reports for the first time a methodology to
prepare both non-porous solid glass microspheres (SGMS) and
highly porous glass microspheres (PGMS) from three borate
glass formulations (i.e. 45B5, B53P4 and 13-93B, derived from
their silicate glass equivalents namely 45S5, S53P4 and 13-93).
The microsphere materials were produced via a novel flame
spheroidisation process and a comparative analysis between
borate SGMS and PGMS conversion to HA, their ion release
and in vitro bioactivity are reported. Moreover, borate PGMS
and converted form of porous HA microspheres were also
tested in vitro, using human mesenchymal precursor stem-
cells as a clinically relevant cell type, to evaluate their ability to
support cell growth and osteogenic potential.
2. Materials and methodology
2.1 Preparation of borate glass formulations investigated
Three different borate glasses (i.e. 45B5, B53P4 and 13-93B),
which were derived from the original 45S5, S53P4 and 13-93
silicate glass equivalents, by fully replacing the SiO2 with B2O3,
were prepared using sodium carbonate (Na2CO3), potassium
carbonate (K2CO3), calcium carbonate (CaCO3), magnesium
carbonate (MgCO3), calcium hydrogen phosphate (CaHPO4),
magnesium hydrogen phosphate trihydrate (MgHPO4·3H2O),
phosphorous pentoxide (P2O5) and boron oxide (B2O3) as start-
ing materials (Sigma Aldrich, UK). The composition of the
borate glasses investigated is shown in Table 1. The required
amounts of precursors were weighed, mixed and transferred to
a platinum rhodium alloy crucible (Birmingham Metal
Company, U.K.) which was then placed into a furnace and fol-
lowed a controlled program using 10 °C min−1 ramp for
melting (i.e. 350 °C for 0.5 hours to remove any residual moist-
ure, then at 800 °C for 0.5 hours to remove CO2 and at 1150 °C
for 1.5 hours to allow for melting). The resulting molten glass
was quenched between two steel plates.
2.2 Manufacturing solid and porous borate glass
microspheres
The three borate glass formulations (45B5, B53P4 and 13-93B,
see Table 1) were processed into solid glass microspheres
(SGMS) and highly porous glass microspheres (PGMS) utilising
a novel single-stage manufacturing process developed in our
group.
The glasses made were ground using a ball mill (Retsch PM
100) and sieved into the particle size range of 63–125 µm and
125–200 µm. Particles in the size range of 125–200 µm were
then processed via a flame spheroidisation process to prepare
SGMS, which utilises an oxy/acetylene flame spray gun (MK 74,
Metallisation Ltd, UK).33,34
To manufacture highly porous microspheres (PGMS), glass
particles in the size range of 63–125 µm were then mixed with
porogen (CaCO3) at a 1 : 3 ratio and processed via flame spher-
oidisation similar to above, again via a single-stage
process.33,34
PGMS of B53P4 and 13-93B were washed using only deio-
nised water for 1 min and the 45B5 PGMS were washed using
0.1 M acetic acid for 1 min, followed by washing using deio-
nised water and industrial methylated spirit (IMS) for quick
drying and then dried at 50 °C overnight. The resulting PGMS
were then sieved again (to gain a similar size range to the
SGMS) and those between 125–200 µm were utilised for
further studies.
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2.3 Phosphate solution used for conversion reaction
Two phosphate solutions with 0.02 M and 0.2 M concentration
were used for the experiments to explore conversion of borate
glass microspheres into HA and were prepared by dissolving
K2HPO4 or Na2HPO4 (for 13-93B) (Reagent grade; Fisher
Scientific, UK) in deionised water. The pH of the starting solu-
tion was adjusted to 7.4, by adding a few drops of dilute HCl.
3. Characterisation methods
3.1 Compositional analysis
Elemental analysis for borate glasses and glass microspheres
(both solid and porous) were conducted via inductively
coupled plasma mass spectroscopy (ICP-MS, Thermo-Fisher
Scientific iCAP-Q equipped with collision cell technology with
energy discrimination, UK) to verify their composition. For
analysis, 0.1 g of borate glass particles/microspheres (before
and after degradation in dil. K2HPO4 and SBF) were digested
in 50 ml 37% HCl until a clear solution was obtained. The
solution was then 50% diluted with Milli-Q water (1 : 1). The
resultant solution was then diluted with 2% HNO3 with 1 : 10
ratio. The final solution was then filtered through a 0.2 µm
syringe filter for ICP-MS analysis. Moreover, blank samples of
pure Milli-Q water were mixed with the same proportion of
HCl and 2% HNO3 using standard calibration solutions. Three
replicates were analysed and their averages are reported.
3.2 Scanning electron microscopy (SEM)
Scanning electron microscopy (Philips XL 30 SEM, UK) with
accelerating voltage of 15 kV and a working distance of 10 m,
was used to examine the surface morphology of microspheres
prepared (solid and porous microspheres), before and after
immersion in degradation media (i.e. SBF and dil. K2HPO4/dil.
Na2HPO4). The microspheres were fixed onto aluminium stubs
with conductive carbon sticky tabs and sputter coated (Agar
Sputter Coater) with platinum prior to examination and viewed
with a Philips XL30 scanning electron microscope. Cross-sec-
tional analyses of the microspheres were achieved by embed-
ding the microspheres in a cold set epoxy resin and polished
with SiC paper followed by a diamond cloth and then coated.
3.3 X-ray diffraction
X-ray diffraction analysis was used to explore the amorphous
nature of each glass formulation including the solid and
porous glass microspheres produced using a Bruker D8
Advanced diffractometer (BRUKER AXS, Germany). The instru-
ment was operated at room temperature and ambient atmo-
sphere with Ni-filtered CuKα radiation (λ = 0.15418 nm), gener-
ated at 40 kV and 35 mA. Scans were performed with a step
size of 0.04° and step time of 8 s over an angular range 2θ
from 8° to 50°. XRD analysis was also used to examine any
deposits on the surface of microspheres during the 21 day
immersion period in SBF and dil. K2HPO4. Phases were identi-
fied using the EVA software (DIFFRACplus suite, Bruker-AXS)
and the International Centre for Diffraction Data (ICDD) data-
base (2005).
3.4 Thermal analysis
Thermal properties of borate glasses and glass microspheres
(solid and porous); glass transition (Tg) (measured at mid-
point), onset of crystallisation (Tx), crystallisation peak (Tc),
melting peak (Tm) temperatures and glass stability against
crystallisation, were characterised using a simultaneous
thermal analysis instrument (SDT, TA Instruments SDT Q600,
USA). Approximately 20 mg of glass samples were placed into a
platinum pan and heated from room temperature to 1100 °C
at 20 °C min−1 heating rate. An empty pan was also run to
determine the baseline, which was then subtracted from the
thermal traces using TA Universal Analysis 2000 software.
3.5 Density measurement
The density of the glass microspheres was determined using a
MicromeriticsAccuPyc 1330 helium pycnometer (Norcross, GA,
USA). The equipment was calibrated using a standard cali-
bration ball (3.18551 cm3) with error of ±0.03%. Glass micro-
sphere samples, with an average weight of approximately 1 g,
were used for the density measurements, and the analysis was
performed in triplicate. The bulk or tap density of the micro-
spheres were also carried out using the following eqn (1).
Density ρð Þ ¼ Weight Wð Þ
Volume Vð Þ ð1Þ
3.6 Porosity measurements
The porosity of the porous microspheres was evaluated via
mercury intrusion porosimetry (Micromeritics Autopore IV
9500). A 5 cc powder penetrometer (Micromeritics) with 1 cc
intrusion volume was used for all of the glass formulations
investigated. Before running the samples, an empty penetrom-
eter test was also carried out as a blank. The porosity of the
microspheres was also calculated using the following eqn (2).




Table 1 Compositions of three different borate glasses investigated
Glass formulation B2O3 (mol%) P2O5 (mol%) CaO (mol%) Na2O (mol%) MgO (mol%) K2O (mol%)
45B5 46.1 2.6 26.9 24.4 0 0
B53P4 53.85 1.72 21.77 22.66 0 0
13-93B 54.6 1.7 22.1 6 7.7 7.9
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3.7 Mass loss, pH and ion release studies
The conversion of borate glass microspheres into HA in a phos-
phate solution was accompanied by a decrease in the mass of
glass microspheres. Therefore, weight loss measurements
provide a useful parameter for monitoring the kinetics of the
conversion reaction. To evaluate the kinetics of material degra-
dation rate, ion release and pH solution changes, 1% w/v of
microspheres were immersed in dil. K2HPO4 or dil. Na2HPO4
and incubated at 37 °C. Assessments were performed on day 1,
3, 7, 10, 14 and 21. To determine the degradation rate, the
microspheres were dried at 50 °C overnight and then weighted
using a precision scale (Sartorius CP 225D). The percentage of
mass loss was calculated according to the following eqn (3):
Mass Loss %ð Þ ¼ M0 Mt
M0
ð3Þ
where M0 is the initial mass (mg) of microspheres and Mt is
the mass obtained at each time point. The pH of the solution
was measured using a microprocessor pH meter (Mettler
Toledo, Switzerland) previously calibrated using standard pH
buffer solutions of pH 4.0, pH 7.0 and pH 10.0 (Fisher
Scientific, UK). The concentration of boron, sodium, calcium,
magnesium, phosphorous and potassium ions was deter-
mined by ICP-MS (Thermo-Fisher iCAP-Q model, UK).
3.8 In vitro SBF bioactivity studies
In vitro bioactivity was tested in simulated body fluid (SBF) at
day 1, 3, 7, 10, 14 and 21. The SBF solution was prepared fol-
lowing the standard procedure BS ISO 23317:2014. The SBF
solution was kept at 5 °C for 48 h prior to use. 75 mg of micro-
spheres (solid and porous) were immersed in 50 ml SBF solu-
tion at 37 °C in a polyethylene vial and agitated at 120 rpm. At
each time point, the microspheres were filtered and washed
with deionised water and then dried overnight at 50 °C in an
oven. XRD, SEM and ICP-MS were utilised to explore the struc-
tural, morphological and compositional changes, respectively.
The pH values of the SBF solution were measured at each time
point. The concentration of boron, sodium, calcium, mag-
nesium, phosphorous and potassium ions in SBF solution at
each time point was also determined by ICP-MS (Thermo-
Fisher iCAP-Q model, UK).
3.9 Cell culture studies
Microspheres were sterilised throughout two washes of
15 minutes with 70% ethanol followed by complete evaporation
at room temperature in sterile conditions as previously
reported.33,35 For this study, GFP-labelled human mesenchymal
stem cells (hMSCs) were seeded at a density of 10 000 cells per
cm2 on 10 mg of sterile material.33 Low-adherent 48-well plates
were prepared using a coating with 200 μl of 1% w/v solution of
poly(2-hydroxyethyl methacrylate) (poly-HEMA) (Sigma-Aldrich,
UK) and 95% ethanol.36 Cells were cultured in standard
medium (low glucose DMEM supplemented with 10% foetal calf
serum, 1% penicillin and streptomycin, 1% L-glutamine, 1% of
non-essential amino acid) at 37 °C and 5% CO2 for 12 days.
3.10 DNA quantitation assay
DNA amount was assayed at day 2 and 12 of culture using the
Pico-Green® dsDNA quantitation kit according to the manu-
facturer’s instructions. Briefly, medium was removed and
100 μl of sterile distilled water were added to each sample,
after three cycles of freezing-thawing, 95 μl were transferred to
a clear bottom 96-well plate for the measurement of fluo-
rescence emission in the microplate reader (Infinite 200,
Tecan, CH), setting 480 nm and 520 nm as excitation and
emission wavelengths.
3.11 Cell imaging
For bright-field and fluorescence images of living cells an
EclipseT2 Nikon microscope coupled with a D3300 Nikon
camera was used. Environmental Scanning Electron
Microscopy was carried out in fixed cells using a FEI Quanta
650 (Thermo Fisher Scientific). Samples were washed twice
with distilled water before imaging in order to remove any ion
precipitation.
3.12 Statistical analysis
For cell culture experiments, results of two independent experi-
ments are presented as mean ± standard error of the mean
(SEM). One-way ANOVA with Tukey’s multiple comparison post
hoc test was used. A 95% confidence level was considered sig-
nificant. Statistical analysis was performed with the GraphPad
PRISM 7.01 software package.
4. Results
4.1 Characterisation of starting glass and microspheres
4.1.1 Surface morphology, XRD and compositional ana-
lysis. Fig. 1 shows that both solid and porous glass micro-
spheres were successfully produced via the flame spheroidisa-
tion processing route.33,34 Fig. 1(Ai, Bi, Ci) and (Aii, Bii, Cii)
confirmed the microsphere morphologies for both the solid
and porous borate-based glass microspheres via SEM analysis.
In order to examine the internal porous structure of the
borate glass microspheres produced, they were embedded in a
cold setting epoxy resin, ground and polished using SiC paper
and diamond cloth, to a depth of a few microns to obtain
microsphere cross-sections.
Fig. 1Aiii, Biii and Ciii represent higher magnification
images of the porous microspheres produced. Whereas,
Fig. 1Aiv, Biv and Civ show representative cross-sections of the
porous 45B5, B53P4 and 13-93B glass microspheres produced,
which not only revealed a large variation of internal pore sizes
(ranging from meso to macropore scales), but also showed that
the pores were fully interconnected throughout each micro-
sphere produced.
The XRD profiles for the starting bulk glass (BG), SGMS
and washed PGMS (i.e. 0.1 M acetic acid for 45B5 and water
for B53P4 and 13-93B) are presented in Fig. 2A, B and C,
respectively, where a single broad peak between 20° and 40°
(2θ) was observed for BG and SGMS (with the exception of
Paper Biomaterials Science

























































































B53P4). The absence of any sharp crystalline peaks suggested
that the glasses prepared were amorphous and that the SGMS
retained their amorphous nature post processing. However,
some peaks were observed for the SGMS from B53P4
which were matched to the sodium calcium phosphate
(Na3Ca6(PO4)5) [JCPDS 11-0236] phase. Literature reported that
the phase Na3Ca6(PO4)5 is highly water soluble and
Na3Ca6(PO4)5 containing calcium phosphate cement could be
used as bone substitute to enhance their bioresorbability.37,38
Peaks were also observed for the PGMS of each composition.
The PGMS peaks were matched for CaCO3 which was used as
the porogen material for manufacturing porous glass micro-
spheres. This suggests that some residual porogen material
remained in the pores of these microspheres, even after the
wash-step.
As EDX analysis can be unreliable for detecting Boron, the
relative elemental concentrations (in mol%) for the BG, SGMS
and PGMS produced from each formulation were analysed via
ICP-MS instead and are summarised in Table 2. It can be seen
that the respective oxide contents for the starting BG were
within 1.5 mol% of their expected values with the exception of
P2O5 and CaO content for B53P4 (which was 2.5 mol% higher
and 2.3 mol% lower, respectively) as compared to their
expected values. No significant variation in chemical compo-
Fig. 1 SEM images of Ai, Bi and Ci for SGMS and Aii, Bii and Cii for PGMS of 45B5, B53P4 and 13-93B glasses. Inset images Aiii, Biii and Ciii show
porous microspheres at higher magnification and Aiv, Biv and Civ show the cross-sectional images of the porous microspheres of three borate
glasses investigated.
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sition between starting BG and SGMS were obtained for all
three glass formulations. However, significantly higher CaO
and lower B2O3 content was observed for the PGMS produced
due to the addition of porogen in this process. For example,
approximately 5 mol% lower B2O3 and 8 mol% higher CaO
was observed for the PGMS produced as compared to the
SGMS for 45B5 (see Table 2).
4.1.2 Density, tap density and porosity measurement.
Table 3 shows the density (measured via He pycnometer), tap
density and theoretical porosity for the SGMS and PGMS of
Fig. 2 X-ray diffraction profiles for (A) starting bulk glass (BG), (B) SGMS and (C) washed PGMS of 45B5, B53P4 and 13-93B borate glasses investi-
gated. ★ represents peaks matched to calcium carbonate (CaCO3) whilst ▼ represents peaks matched to sodium calcium phosphate
(Na3Ca6(PO4)5).
Table 2 Compositional analysis of starting bulk glass (BG), SGMS and PGMS of 45B5, B53P4 and 13-93B glasses via ICP-MS
Glass code Different forms
Composition (mol%)
B2O3 P2O5 CaO Na2O MgO K2O
45B5 BG Expected 46.1 2.6 26.9 24.4 N/A N/A
Actual 47.08 ± 0.19 2.96 ± 0.01 26.33 ± 0.09 23.33 ± 0.05 N/A N/A
47.70 ± 0.04 2.86 ± 0.02 26.42 ± 0.09 22.80 ± 0.02 N/A N/A
42.90 ± 0.04 2.97 ± 0.01 34.12 ± 0.03 19.74 ± 0.02 N/A N/A
B53P4 BG Expected 53.85 1.72 21.77 22.66 N/A N/A
Actual 54.36 ± 0.08 4.22 ± 0.05 19.43 ± 0.02 21.81 ± 0.04 N/A N/A
54.54 ± 0.01 4.22 ± 0.01 19.64 ± 0.01 21.42 ± 0.02 N/A N/A
49.11 ± 0.26 3.85 ± 0.01 27.56 ± 0.21 19.26 ± 0.03 N/A N/A
13-93B BG Expected 54.6 1.7 22.1 6 7.7 7.9
Actual 55.43 ± 0.22 1.91 ± 0.01 21.61 ± 0.08 5.94 ± 0.12 7.35 ± 0.01 7.77 ± 0.01
55.40 ± 0.18 1.90 ± 0.01 21.88 ± 0.18 5.91 ± 0.01 7.33 ± 0.01 7.58 ± 0.01
49.68 ± 0.20 1.77 ± 0.01 29.77 ± 0.2 5.27 ± 0.03 6.68 ± 0.02 6.83 ± 0.02
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45B5, B53P4 and 13-93B. The density and tap density reduced
significantly when comparing SGMS to PGMS. However, the
calculated theoretical porosity increased 2–3 fold for the PGMS
for all glass compositions when compared to SGMS. For
example, on average across the formulations, the density and
tap density for the SGMS was found to be around 2.4 and 1.7 g
cm−3, respectively. Whereas, the density and tap density for
the PGMS was found to be around 2.3 and 0.5–0.8 g cm−3,
respectively. In addition, the theoretical calculated porosity
(which was likely to be inter-particulate gaps for the SGMS),
and actual porosity along with inter-particulate gaps was
found to be 27–31 and 65–75%, for the SGMS and PGMS,
respectively. Moreover, the theoretically calculated (%) porosity
values (using eqn (2)) for PGMS were found to be similar to
the actual experimental data obtained via mercury porosimetry
(see Table 3).
The pore diameters obtained (measured via mercury porosi-
metry versus the log differential pore volume) are presented in
ESI Fig. 1.† It should be noted that mercury porosimetry deter-
mines the largest entrance to a space as a pore which is not
always the actual “pore size” as it will also include inter-par-
ticulate gaps.39 The PGMS from all three glasses revealed
multimodal pore size distribution with the first prominent
peak showing a modal value range of ca. 43–52 µm, the second
peak at ca. 20–28 µm and a third peak at ca. 2–5 µm. More
interestingly, this analysis revealed pore size features at submi-
cron scales ranging to nanoscale porosity levels down to 10 nm
as shown in ESI Fig. 1.†
4.2 Immersion of solid and porous borate glass
microspheres in phosphate solutions
4.2.1 Mass loss and pH change in 0.02 M K2HPO4. Fig. 3
shows the mass loss (%) and pH change as a function of
immersion time in 0.02 M K2HPO4 solution for SGMS and
PGMS for the borate glass formulations explored. The mass
loss (%) increased with time for both SGMS and PGMS from
each formulation, eventually reaching a plateau (see Fig. 3A).
Also, Fig. 3A revealed a higher mass loss (%) for PGMS com-
pared to their respective SGMS (with the exception of B53P4,
from day 10 onwards). Moreover, the data also showed the
highest reaction rate observed was also for B53P4 which
revealed an approximate 52% mass loss for the PGMS by day 7
and 60% mass loss for SGMS attained by day 14. Whereas, in
comparison, approximately 40% mass loss was observed for
PGMS of 45B5 by day 14 and 25% mass loss for SGMS by day
21. On the other hand, the lowest mass loss (19% for PGMS
and 14% for SGMS) was observed for 13-93B glass and no
plateau was seen for both SGMS and PGMS of 13-93B during
the 21-day duration of these studies.
In general, the pH values in phosphate solution increased
from 7.4 to 10 by day 3, then gradually decreased to approxi-
mately neutral (i.e. 7.6) by day 10 and then remained relatively
constant for the remainder of the study as seen in Fig. 3B.
4.2.2 Ion release studies in 0.02 M K2HPO4 solution. The
ion release profiles for both SGMS and PGMS were investigated
via ICP-MS, recording the concentration of B, Na+, P, K+, Ca2+
and Mg2+ ion in 0.02 M K2HPO4 solution presented as cumu-
lative ion release profiles (see Fig. 4A–F).
The boron and sodium ion release profiles for both SGMS
and PGMS from all three borate glasses increased with increas-
Fig. 3 (A) Mass loss and (B) pH change as a function of immersion time
(days) of SGMS and PGMS from three different borate glasses in 0.02 M
K2HPO4 solution at 37 °C over 21 day duration. Solid symbols represent
SGMS, whilst the open symbols represent the porous counterparts.
Table 3 Density, tap density and porosity of SGMS and PGMS produced from the three borate glasses under investigation
Formulation Density Tap density % Porosity (calculated) % Porosity (Hg porosimetry)
45B5 SGMS 2.496 ± 0.004 1.72 ± 0.03 31.10 N/A
PGMS 2.286 ± 0.004 0.82 ± 0.02 64.13 66 ± 4
B53P4 SGMS 2.432 ± 0.002 1.75 ± 0.02 28.05 N/A
PGMS 2.361 ± 0.005 0.65 ± 0.3 74.17 71 ± 5
13-93B SGMS 2.425 ± 0.006 1.76 ± 0.02 27.82 N/A
PGMS 2.302 ± 0.006 0.50 ± 0.3 78.28 75 ± 4
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ing immersion time to a plateau. The ion release rate was
higher for PGMS compared to their SGMS counterpart. For
example, cumulative boron release was 1311 ppm for PGMS
and 836 ppm for SGMS of 45B5 at day 14. Similarly, higher K
and Mg ion release were observed for PGMS of 13-93B com-
pared to SGMS during the study. On the other hand, the oppo-
site trend of Ca2+ ion release profile was observed for SGMS
and PGMS, where the Ca2+ ion release for the SGMS was
higher in comparison to their respective PGMS. However, the
overall Ca2+ ion release was negligible in comparison to B or
Na ion release.
Fig. 4C shows that the concentration of P ions in solution
decreased for both SGMS and PGMS from the borate glasses
with increasing immersion time. The reduction of P ion from
the solution was higher for PGMS in comparison to their
SGMS counterpart. For example, the concentration of P ion
reduced from 623 ppm (starting concentration) to 68 ppm by
day 10 for PGMS of B53P4. Whereas, P ion for SGMS of the
same glass was found to be 466 ppm at the same time point.
Interestingly, the P ion concentration reached a negative value
for the PGMS of 45B5 at day 10 which then plateaued from
Day 14 to 21. Similarly, depletion of K ions was observed for
both SGMS and PGMS of 45B5 and B53P4 glasses (which did
not have any K in their formulation) with the exception of 13-
93B.
4.2.3 XRD analysis post immersion in 0.02 M K2HPO4.
XRD spectra for both SGMS and PGMS from the different
borate glasses, post immersion in 0.02 M K2HPO4 solution, are
Fig. 4 Cumulative ion release profile of (A) borate, (B) sodium, (C) phosphate, (D) potassium, (E) calcium and (F) magnesium ions as measured via
ICP-MS for both SGMS and PGMS from the glasses investigated, over 21 days immersion in 0.02M K2HPO4. (Error bars are also included in the data
above.) Black dashed lines represent for starting ion concentration of solution.
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shown in Fig. 5. The major peaks observed in the patterns cor-
responded to standard hydroxyapatite (HA, Ca10(PO4)6(OH)2,
JCPSD 72-1243), indicating that the borate glasses had been
converted to HA.
For 45B5 a HA peak was observed at day-14 for the SGMS,
whereas for the PGMS a HA peak was observed at a much
earlier time point (i.e. formed between days 3 to 10) as seen in
Fig. 5A. Moreover, the peak intensities were greater for all time
points observed for the PGMS.
However, for the PGMS of B53P4 a HA peak was observed at
day-3, which increased in intensity by day 21.
Surprisingly, no HA peak was observed for both the SGMS
and PGMS of 13-93B even up to 28 days immersion in 0.02 M
K2HPO4 solution (see Fig. 5C). The CaCO3 peaks observed were
most likely due to the remaining presence of porogen residue
in the PGMS even after washing.
4.2.4 SEM analysis post immersion in 0.02 M K2HPO4 at
day 21. Fig. 6 represents SEM images at different magnifi-
cations for SGMS and PGMS of 45B5, B53P4 and 13-93B borate
glasses at day 21 post immersion in 0.02 M K2HPO4 solution.
It can be seen (especially from the higher magnifications from
Fig. 6A and B) that HA had formed on the surface of SGMS
and on both the upper surface and within the inner porosity of
the PGMS of 45B5 and B53P4. However, no HA formation was
observed on the surface of both SGMS and PGMS of 13-93B at
the same time point (see Fig. 6C).
In order to investigate if any changes had occurred to the
internal morphology of both SGMS and PGMS post immersion
in 0.02 M K2HPO4 solution at day 10 and 21, cross-sectional
analysis of the microspheres was carried out and is presented
in ESI Fig. 2.† The cross-sections at day-0 (i.e. starting micro-
spheres) are also highlighted for comparison.
The SGMS behaved differently during the immersion in
0.02 M K2HPO4 solution. For example, the conversion reaction
for the SGMS of 45B5 seemed to start from the outer surface
and moved inward with increasing immersion time with mul-
tiple layers observed at day 21 (highlighted in dashed red
circles, see ESI Fig. 2†). Surprisingly, hollow microspheres for
SGMS of B53P4 were observed (as highlighted in dashed red
circles with yellow arrow at day 10 and at day 21, see ESI
Fig. 2†). On the other hand, a large solid core and small areas
of degraded outer surfaces were observed for SGMS of 13-93B
at day 21 (also highlighted in dashed red circles, see ESI
Fig. 2†).
EDX analyses of the cores of the cross-sectioned micro-
spheres (at day 0, 10 and 21) were also conducted to observe
the presence (highlighted in red ) and disappearance (high-
lighted in black) of boron and the representative EDX spectra
Fig. 5 X-ray diffraction pattern for both (i) SGMS and (ii) PGMS of three borate glass formulations (A) 45B5, (B) B53P4 and (C) 13-93B during immer-
sion of microspheres in 0.02 M K2HPO4 solution at 37 °C over time. XRD spectra for HA is shown at the base of each figure for comparison. ★ high-
lights peaks for calcium carbonate (CaCO3).
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are shown in Fig. 7. Point spectra at core from various micro-
spheres were obtained (shown as ‘+’ symbol, see ESI Fig. 2†).
The presence of boron was observed for SGMS of 45B5 at day
21 post immersion (see Fig. 7). Whereas, no boron was
observed for PGMS at day 21, which disappeared at some point
between day 10 and day 21. Interestingly, no boron was also
observed for the SGMS of B53P4 at day 21. Furthermore, the
boron peak also disappeared earlier than day 10 for the PGMS.
However, the presence of boron was observed for both SGMS
and PGMS of 13-93B even till day 21 (see Fig. 7).
As mentioned earlier, it should be noted that quantitative
analysis for boron containing compounds cannot be measured
accurately via EDX analysis. Therefore, further compositional
analysis of the microspheres was conducted via ICP-MS, post
immersion in 0.02 M K2HPO4 solution for the day 21 samples.
4.2.5 Compositional analysis via ICP-MS at day 21. Table 4
represents the compositional analysis (in mol%) obtained via
ICP-MS for SGMS and PGMS post immersion in 0.02 M
K2HPO4 at day 21. It was seen that very negligible (less than
1 mol%) amount of B2O3 and Na2O were observed for PGMS of
45B5 and for both SGMS and PGMS of B53P4. The Ca/P
(atomic) ratio for them was found to be around 1.4. However,
high B2O3 levels were still observed for some samples at day 21
post immersion (for e.g. 35 mol% for SGMS of 45B5, 35 and
50 mol% for PGMS and SGMS of 13-93B, respectively).
Moreover, 2–6 mol% Na2O still remained for SGMS of 45B5
and for both SGMS and PGMS of 13-93B. In addition, small
amounts of K2O were also observed for all the borate glass
formulations.
4.2.6 Immersion of 13-93B microspheres at higher concen-
tration (0.2 M K2HPO4). As the 13-93B formulation seemed to
be unreactive, we increased the concentration of the phos-
phate solution and immersed both SGMS and PGMS of 13-
93B in 0.2 M K2HPO4 up to day 28 (alongside microspheres of
B53P4 for comparison, as it had converted to HA in 0.02 M
K2HPO4 solution at earlier time point). Fig. 8A and B show
Fig. 6 SEM images Ai, Bi and Ci for SGMS and Aii, Bii and Cii for PGMS of 45B5, B53P4 and 13-93B post immersion in 0.02 M K2HPO4 solution at
37 °C at day-21. Inset images show individual microsphere at higher magnification.
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Fig. 7 EDX analysis for the cross-sections of SGMS and PGMS of 45B5, B53P4 and 13-93B at day-0 (starting microspheres), day-10 and day-21
during the immersion of microspheres in 0.02 M K2HPO4 solution at 37 °C. EDX spectra shown for core of each cross-sections of microspheres, as a
representative. Red circle highlights the presence of boron and black circle highlights the absence of boron.
Table 4 Compositional analysis for SGMS and PGMS of borate glasses post immersion in 0.02 M K2HPO4 at day 21
Components
45B5 B53P4 13-93B
SGMS (mol%) PGMS (mol%) SGMS (mol%) PGMS (mol%) SGMS (mol%) PGMS (mol%)
B2O3 35.96 ± 2.90 0.77 ± 0.09 0.84 ± 0.02 0.39 ± 0.04 50.74 ± 0.27 35.62 ± 1.23
P2O5 9.68 ± 1.47 25.88 ± 0.09 26.01 ± 0.09 26.42 ± 0.06 4.11 ± 0.12 8.16 ± 0.31
CaO 47.86 ± 3.63 71.68 ± 0.22 71.41 ± 0.14 71.59 ± 0.14 26.81 ± 0.11 42.48 ± 1.17
Na2O 5.86 ± 2.22 0.30 ± 0.01 0.62 ± 0.01 0.34 ± 0.01 4.3 ± 0.01 2.05 ± 0.11
MgO — — — — 8.27 ± 0.08 8.78 ± 0.01
K2O 0.34 ± 0.01 0.92 ± 0.01 0.83 ± 0.09 0.83 ± 0.02 5.78 ± 0.03 2.92 ± 0.14
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X-ray diffraction pattern for both SGMS and PGMS of B53P4
and 13-93B post immersion in 0.2 M K2HPO4 solution at
37 °C. A HA peak was observed at much earlier time point
(day 1) for PGMS of B53P4 when immersed in ten time’s
higher concentration of K2HPO4 solution (see Fig. 8A).
However, no HA peak was observed for the SGMS at the same
time point. Surprisingly, no HA peak was observed for both
SGMS and PGMS of 13-93B even at day 28 post immersion in
0.2 M K2HPO4 solution (see Fig. 8B). Therefore, one further
attempt was made using an alternative phosphate solution
(Na2HPO4) and only for PGMS of 13-93B.
4.2.7 Comparison of 13-93B-PGMS in 0.02 M and 0.2 M
Na2HPO4 solutions. Fig. 9A represents the mass loss % for
PGMS of 13-93B at two different concentrations of Na2HPO4
solution with immersion time. The mass loss % increased
with increasing immersion time in both concentrations (i.e.
0.02 M and 0.2 M) and plateaued at day 14 (for 0.2 M). The
mass loss of the microspheres was higher in 0.2 M compared
Fig. 8 X-ray diffraction pattern for both SGMS and PGMS of (A) B53P4 at day 1 and (B) 13-93B at day 28 in higher 0.2 M K2HPO4 concentration solu-
tion at 37 °C. HA was identified at day 1 for the porous B53P4 microspheres in comparison to SGMS. Whereas, no HA was seen for 13-93B, even up
to day 28. ★ highlights peaks for calcium carbonate (CaCO3).
Fig. 9 (A) Highlights mass loss for PGMS of 13-93B in (0.02 M and 0.2 M) Na2HPO4 versus immersion time (days), (B) shows the X-ray diffraction pat-
terns at day 28 and SEM images for PGMS of 13-93B post immersion of microspheres in (C) 0.02 M Na2HPO4 and (D) 0.2 M Na2HPO4 solution at
37 °C at day-28. Inset images show microspheres at higher magnification. XRD spectra for HA shown at the bottom of B for comparison. ★ high-
lights peaks for calcium carbonate (CaCO3).
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to 0.02 M Na2HPO4 solution. Values observed were 40% in 0.2
M Na2HPO4 solution at day 14 which remained constant for
the remainder of the study. On the other hand, mass loss for
the microspheres at day 28 post immersion in the lower 0.02
M Na2HPO4 solution was found to be only 28%. Moreover, no
plateau was observed within the 28 day study duration.
Fig. 9B represents the XRD spectra for PGMS of 13-93B at
day 28 post immersion in Na2HPO4 solution at the two
different concentrations. Interestingly, a HA peak was observed
for the microspheres in both concentrations (i.e. 0.02 M and
0.2 M). However, more intense HA crystalline peaks were seen
for the microspheres in 0.2 M Na2HPO4 compared to 0.02 M
Na2HPO4 solution. In addition, CaCO3 peaks were still present
at day 28 post immersion in the lower 0.02 M Na2HPO4
solution.
Fig. 9C and D show the SEM images at different magnifi-
cations for PGMS of 13-93B at day 28 post immersion in 0.02
and 0.2 M Na2HPO4 solution at 37 °C, respectively. It can be
seen from both figures at higher magnification that HA had
formed on both the upper surface and within the inner poro-
sity of the PGMS of 13-93B in both concentrations when
Na2HPO4 solution was utilised (and did not form any HA when
using K2HPO4).
4.3 In vitro bioactivity studies
4.3.1 XRD and SEM analysis. XRD profiles for SGMS and
PGMS of 13-93B (as a representative) post immersion in SBF at
37 °C at various time points, are shown in Fig. 10A and B,
respectively. XRD profiles for the SGMS and PGMS of 45B5 and
B53P4 are shown in ESI Fig. 3.† The major peaks in the pat-
terns corresponded to those of a standard HA,
Ca10(PO4)6(OH)2 (JCPSD 72-1243), indicating the formation of
HA occurred during immersion in SBF. HA peaks were
observed at day 7 for PGMS of all glass formulations and the
peak intensities increased with increasing immersion time.
However, a HA peak was observed at a later time point (day 10)
for SGMS of 45B5 and B53P4 with increasing peak intensities
seen with increasing time (see ESI Fig. 3A and B†). It should
also be noted that a HA peak was observed for SGMS of 13-93B
at day 14 when immersed in SBF (see Fig. 10A). Fig. 10C and D
represent SEM images at different magnifications of SGMS
and PGMS for 13-93B at day 21 post immersion in SBF. SEM
images for SGMS and PGMS of the other borate glasses (i.e.
45B5 and B53P4) are shown in ESI Fig. 4.† It can be seen at
higher magnification that HA had formed on the surface of
SGMS and on both the upper surface and within the inner
porosity of PGMS of all three borate glass formulations
immersed in SBF (see Fig. 10 and ESI Fig. 4†).
4.3.2 Ion release studies in SBF. The ion release profiles
for both SGMS and PGMS were investigated via ICP-MS ana-
lyses, recording the concentration of B, Na+, Ca2+, P, K+ and
Mg2+ ion in SBF presented as cumulative ion release profiles
(see ESI Fig. 5A–F†).
The boron, sodium and calcium ion release profiles for
both SGMS and PGMS of all the borate glasses investigated
increased with increasing immersion time before reaching a
plateau. The ion release rate was higher for PGMS compared to
their SGMS counterparts. For example, boron release was
178 ppm for PGMS of 45B5 at day 10 after that the value
remained constant. Whereas, boron release was 134 ppm for
Fig. 10 X-ray diffraction patterns for both (A) SGMS and (B) PGMS of 13-93B post immersion in SBF at 37 °C up to day 21. XRD spectra for HA is also
shown at the bottom of each figure for comparison. SEM images (C) SGMS and (D) PGMS of 13-93B post immersion in SBF at day 21. Inset images
shown at higher magnification.
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the SGMS at day 10. Similarly, higher K and Mg ion release
were observed for PGMS of 13-93B compared to SGMS before
achieving a plateau at day 7.
ESI Fig. 5D† shows that the concentration of P ions
decreased for both SGMS and PGMS from the borate glasses
with increasing immersion time. The reduction of P ion from
SBF was higher for PGMS in comparison to their SGMS
counterpart. Interestingly, the P ion concentration achieved a
negative value for both SGMS and PGMS at day-21. Similarly,
depletion of Mg ions was observed for both SGMS and PGMS
of 45B5 and B53P4 glasses over the bioactivity SBF study.
4.3.3 pH measurements of SBF. ESI Fig. 6† represents the
variation of pH change as a function of immersion time (day)
of the SGMS and PGMS of all three borate glasses in SBF at
37 °C over 21 days. In general, the pH values in SBF remained
relatively neutral with slight increases from 7.4 to 7.9 observed
at day 3, which gradually decreased to 7.6 by day 10 and then
remained relatively constant for the remainder of the study
(see ESI Fig. 6†).
4.3.4 Compositional analysis via ICP-MS for bioactivity
study. ESI Table 1† represents the compositional analysis (in
mol%) obtained via ICP-MS for SGMS and PGMS of the borate
glasses post immersion in SBF at day 21. The Ca/P (atomic
ratio) was found to be around 1.5 for both SGMS and PGMS of
each glass compositions.
4.4 Cell culture study
A cell culture study was conducted to compare the influence of
Boron containing microspheres versus the HA converted borate
microspheres. Fluorescently-labelled human mesenchymal
stem cells were seeded and cultured for 12 days on 45B5 and
B53P4 PGMS sample as prepared and converted to HA (in 0.02
M K2HPO4). Live fluorescence imaging performed at day 2
showed the formation of macro-aggregates of cells and micro-
spheres for the HA converted form of both formulations, while
no signal was detected in cultures seeded on the boron con-
taining unconverted counterparts (see Fig. 11A). Observation
of the cultures at day 12 confirmed this trend, with signifi-
Fig. 11 Evaluation of cell response to unconverted and converted (in 0.02 M K2HPO4) forms of PGMS of 45B5 and B53P4 borate glass at day 2 and
day 12. (A) Representative live fluorescence images of cell-microspheres aggregates 48 hours after seeding. (B) Semi-quantitation of DNA amount
at day 12 in the converted form normalised to the unconverted counterpart. Dotted line corresponds to the value of 1 of the normalisation.
(C) Representative ESEM images obtained at day 12 of culture for unconverted and converted forms of both formulations. Yellow arrows point at
round cells protruding from the material surface while yellow arrowheads points at flat cells attached to the microspheres.
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cantly higher values for samples grown on the HA converted
versus unconverted materials (see Fig. 11B). ESEM imaging
performed at day 12, evaluated the cell–microsphere inter-
actions and showed that cells appeared flat and adhered to the
microsphere surface and pores of the HA converted forms (see
Fig. 11C, arrowheads). Conversely, cells cultured on the boron
containing unconverted microspheres appeared mainly
rounded, with protrusions onto the material surface (see
Fig. 11C, arrows).
5. Discussion
It is not surprising that Hydroxyapatite (HA), the main in-
organic constituent of bones and teeth, has been one of the
most widely researched biomaterials, which exhibits natural
bioactive behaviour and excellent biocompatibility.40,41 The
performance of HA for bone regeneration greatly depends on
its morphology, three-dimensional (3D) structure and chemi-
cal composition.42 As highlighted in the introduction, several
studies report on developing porous HA microspheres which
usually involve using template-based supports, harmful
organic solvents, structure-directing reagents.10,11,13,17,43,44
Furthermore, these microspheres only possessed mesopores
(ranging from ∼2 nm–0.6 µm), which would not be suitable for
cell incorporation.31
Studies also showed that borate-based glasses can undergo
complete conversion to HA due to their higher solubility.26
However, the conversion rates can be influenced by their mor-
phology and glass compositions. For example, Huang et al.
(working with Professor Day and Professor Rahaman) investi-
gated the conversion of 45B5 solid glass microspheres (i.e. a
glass formulation which replaced all the SiO2 in the original
45S5 glass with B2O3) in dilute potassium phosphate solu-
tion.26 XRD and compositional analysis of the microspheres
produced (which were in the size range of 800–1000 µm)
revealed only partial conversion to HA after 310 h (i.e. 13
days).26 This paper set out to explore the hypothesis that pro-
ducing highly porous glass microspheres (PGMS) from borate
glasses would lead to complete conversion to HA and at a sig-
nificantly faster rate. Three borate glass formulations were
investigated (45B5, B53P4 and 13-93B) which were all derived
based on 45S5, S53P4 and 13-93 biosilicate glasses, respect-
ively by fully replacing the SiO2 with B2O3.
5.1 Manufacturing solid and porous borate glass
microspheres
The results confirmed successful manufacture of both solid
(SGMS) and highly porous glass microspheres (PGMS) from all
three borate glass compositions. It has only recently become
possible to produce such highly porous glass microspheres,
due to a unique processing method established in our group.
The cross-sectional SEM images of the PGMS for all three glass
formulations investigated (see Fig. 1) revealed their internal
porosity, which clearly showed that the pores were fully inter-
connected throughout each of the microspheres produced.
The glass particles were transformed into microspheres due to
surface tension forces during the cooling stage as the molten
glass globules were ejected out of the flame as mentioned else-
where.45 This novel and rapid method of manufacturing
highly porous glass microspheres was first demonstrated for
manufacturing highly porous microspheres from phosphate
based glasses, which has now been transferred to borate
glasses, for the first time.33 The yield in terms of porosity and
pore sizes of the porous glass microspheres produced depends
on various factors such as the size of the starting glass par-
ticles, glass powder to porogen ratio and the oxy-acetylene
flame ratios used. Recent studies on phosphate glass micro-
spheres from our group have reported on porosity levels
ranging from 52 (±5) to 76 (±5) % by varying the glass particles
to porogen ratios from 1 : 1 to 1 : 3.33 They also showed that the
size of the starting microparticles effected pore size. For
example, the porous microspheres between 63 and 125 µm
revealed a significant number of larger surface pores (55 ±
8 µm) compared to the larger diameter size range porous glass
microspheres (i.e. between 200 and 300 µm) which revealed a
larger number of smaller surface pores (ranging from macro-
porous sized features up to 30 µm).33
As borate glasses are highly degradable in acidic media, a
very low concentration of acetic acid for 45B5 PGMS, whilst
only water for B53P4 and 13-93B PGMS was utilised for the
sample wash step to remove any residual porogen remnants
post spheroidisation. However, the XRD results (see Fig. 2C)
showed that porogen remnants were not completely removed,
which was due to them being trapped deep inside the porous
microspheres (confirmed via XRD; see Fig. 2C).
SGMS from 45B5 and 13-93B remained fully amorphous
whereas the SGMS of B53P4 crystallised, revealing peaks for
the phase sodium calcium phosphate [Na3Ca6(PO4)5] identi-
fied from XRD analysis (see Fig. 2B). This crystallisation was
attributed to the lower glass stability (52 °C) of the B53P4 com-
position compared to 45B5 (104 °C) and 13-93B (198 °C), as
highlighted in ESI Table 2 and ESI Fig. 7.†
In addition, the relatively higher (2.5 mol%) content of
P2O5 in B53P4 compared to the expected value of P2O5 may
also have aided the crystallisation process (see Table 2). A
study on the influence of phosphorus speciation on the phase
separation of Na2O–B2O3–SiO2 glasses by Muñoz et al. reported
that the larger ionic field strength of P5+ cations (2.1) com-
pared to those of Si4+ (1.57) and B3+ (1.63 and 1.34, for three
and four-fold coordinated boron atoms, respectively) increased
the tendency of phosphorus to separate from the borosilicate
network, thus leading to crystalline phase separation of the
phosphate species.46
5.2 Rapid conversion of borate glass microspheres to HA
The mechanism for HA formation on 45S5 silicate glass is well
established where the first step is the formation of a SiO2-rich
gel layer by ion exchange reactions, followed by dissolution of
Ca2+ and PO4
3− ions and their diffusion through the SiO2-rich
gel layer, leading to formation of an amorphous calcium phos-
phate (ACP) layer on the SiO2 gel which then converts to HA.
47
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The conversion of borate glasses to HA seems to follow a
mechanism similar to that for 45S5 glass, however without for-
mation of a SiO2-rich layer.
20 Prof. Day and co-
workers20,24,26,30,48 were the first to explore conversion of
borate glasses to HA. They reported that borate glasses con-
verted completely to HA at a faster rate compared to 45S5 glass
and a wide range of HA structures, ranging from pseudo-
morphic nanoporous particles to pseudomorphic hollow
microspheres, can be produced due to the structural changes
occurring during the conversion reaction.
Mass loss profiles for borate glass microspheres (both
SGMS and PGMS) in this study correlated entirely to their ion
release profiles, and especially to the borate and sodium
release profiles (see Fig. 3A and 4A). The Na+ and BO4
3− ions
were released into solution, whereas Ca2+ ions from the glass
reacted with PO4
3− from the solution to form HA and conse-
quently, depletion of phosphate ions from solution was
observed (see Fig. 4C) which plateaued by day 14 for 45B5-
PGMS and day 10 for B53P4-PGMS suggesting the reaction had
completed.
Based on the results (i.e. mass loss, ion release, XRD and
compositional analysis) obtained, comparisons for the conver-
sion of SGMS and PGMS to HA post immersion in 0.02 M
K2HPO4 solution are summarised in Table 5.
The conversion rates were much faster for the PGMS (of
45B5 and B53P4) in comparison to their SGMS counterparts,
which was expected due to their increased surface area achieved
from the starting materials.33 It was also apparent that conver-
sion rate depended on glass composition, as the SGMS from
three borate glasses revealed different conversion reaction pro-
files (e.g. 45B5-SGMS revealed formation of varying HA layers
and remained unconverted at its core, whereas B53P4-SGMS
revealed formation of hollow HA microspheres; see ESI Fig. 2†).
The earlier complete conversion for SGMS of B53P4 compared
to 45B5 could be attributed to the presence of highly water
soluble Na3Ca6(PO4)5 phase in their structure which accelerated
the conversion process.37,38 The compositional analysis at day
21 revealed that non-stoichiometric HA (Ca/P was approximately
1.4) formed for completely converted borate glass microspheres
(i.e. PGMS of 45B5, and SGMS and PGMS of B53P4) in 0.02 M
K2HPO4 solution due to the presence of trace amounts of Na,
Mg and K in their HA crystal structure.49
The conversion of SGMS to HA started from the outer
surface, moving inward with increasing immersion time.
Whereas, the conversion reaction for PGMS occurred from
both the upper surfaces and from within through the pores
created during production. Based on the ion release profiles
and compositional analysis (via ICP-MS), the mechanism for
the conversion of borate SGMS vs. PGMS (i.e. 45B5) to HA is
depicted in Fig. 12.
5.3 Troublesome 13-93B
No conversion reaction was observed for both SGMS and
PGMS of 13-93B in both the 0.02 M K2HPO4 and at the higher
0.2 M K2HPO4 concentration by day 28 (see Fig. 5C and 6C).
Whereas, at the higher (0.2 M) concentration, HA peaks were
observed much earlier (day 1) for PGMS of B53P4 as compared
to 0.02 M K2HPO4 (at day 3). The lack of conversion of 13-93B
glass microspheres to HA in K2HPO4 solution could be attribu-
ted to the presence of potassium in both the starting glass
microsphere formulations and solution utilised, which may
have inhibited the ion exchange reaction. However, PGMS of
13-93B did convert to HA in Na2HPO4 solution and a faster
conversion rate was observed at higher concentration (i.e. 0.2
M) compared to 0.02 M Na2HPO4 solution.
5.4 In vitro bioactivity in SBF
Both SGMS and PGMS from all three borate glasses showed
bioactivity in SBF (see Fig. 10 and ESI Fig. 3, 4 and ESI
Table 1†). However, the PGMS showed much earlier bioactivity
as compared to their SGMS counterparts (as predicted in our
hypothesis, due to their higher surface area). Compositional
analysis at day 21 revealed that non-stoichiometric HA (Ca/P
ratio 1.5) formed for both SGMS and PGMS of all borate
glasses.49
It was observed that borate leached out almost completely
from SGMS of 45B5 and 13-93B (i.e. complete conversion) in
SBF, which was not observed in 0.02 M K2HPO4 solution. This
could be attributed to the presence of TRIS buffer in SBF
which accelerated the dissolution of borate glass microspheres
in comparison to the potassium phosphate solution.50 The
effect of TRIS buffer on degradation rate of silicate 45S5
scaffolds has been investigated by Rohanová et al. who
reported that the scaffold material dissolved twice as fast in





10–14 Between days 14–21 Evidence
45B5 SGMS — — Partially converted (HA layers formed on
periphery and not down to the inner core)
XRD + SEM + EDX + ICP-MS + cross-
sections see Fig. 5, 6, and 7, Table 4 and,
ESI Fig. 2†PGMS — Completely
converted
—







SGMS — — Not converted
PGMS — — Not converted
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TRIS buffer compared to dH2O.
50 The significant reduction of
material mass in the solutions containing TRIS buffer confirmed
the accelerated dissolution of scaffolds, in comparison with solu-
tions without TRIS buffer.50 Therefore, further rapid conversion
rate for borate glass microspheres may well be achieved using
TRIS buffer in K2HPO4 and/or Na2HPO4 solution.
5.5 Cell culture study
To evaluate biocompatibility of the HA PGMS developed,
human mesenchymal cells were used as a clinically relevant
cell model. PGMS of 45B5 and B53P4 which had been con-
verted (in 0.02 M K2HPO4) to HA revealed significantly
enhanced biological properties supporting cell adhesion and
growth for up to 12 days in vitro, whilst no significant cell
growth was detected on the unconverted forms. These obser-
vations are suggested to be due to a combined effect of glass
surface stability and ion release rates. Approximately 25–50%
mass loss was observed for the unconverted forms in 0.02 M
K2HPO4 solution during the first 3 days, for both formulations,
which could have inhibited the initial cell adhesion necessary
to establish stable cell–material interaction.51 The second criti-
cal factor was the amount of ions released from the materials
to the cell culture medium, particularly with regard to borate.
In vitro studies using boron-doped bioglass materials have
attributed a dual biological effect to this ion, with concen-
trations of borate in cell culture of up to 0.65–1.5 mmol associ-
ated with an increase of cell proliferation, while for higher
values a decrease of cell growth has been reported.52,53 In the
present study, the burst release of borate observed for the
unconverted forms during the first 24 h resulted in a concen-
tration of between 500 and 1100 ppm (46 mmol–102 mmol),
which most likely contributed to inhibition of cell growth.
Interestingly, a previous study reported a more favourable cell
response using partially converted materials in comparison to
fully converted ones, which may be due to a residual release of
ions (calcium, borate and sodium) from the partially converted
forms exerting a favourable effect on the cells.54
The porous conformation of the materials presented in this
study is a clear advantage for future applications in tissue
engineering as it would enable cells to grow in 3D environ-
ments which more closely resemble the native tissue in vivo.55
In the context of porous materials, pore structure and porosity
are both key factors of scaffolds in tissue engineering.
However, the results available in the literature are still contrast-
ing and the optimal values for successful outcomes are yet to
be defined. For instance, studies comparing pore sizes in the
range of 50–500 µm found more bone formation associated
with larger pore values.56–58 Conversely, in another study
scaffolds with 100 µm pore size seemed to perform better than
the 250 and 400 µm-pore counterparts.59 It is worth noting
that porous calcium phosphate microspheres with similar
pore structure to that reported in this study promoted cell
colonisation towards the core of the microsphere in vitro and
induced tissue ingrowth and osteogenic onset in vivo.60
In summary, the present cell culture observations indicated
much improved biological properties for PGMS post full con-
version, which warrants a future comprehensive evaluation of
their osteogenic potential in vitro and also of their regenerative
potential in vivo. Indeed, formation of HA materials is still
appealing for bone repair applications, as HA is known for its
osteoinductive properties and HA-based devices are already in
clinical use.61 The converted PGMS in this study combined the
Fig. 12 (A) Mechanism for the conversion of borate glass microspheres into HA in phosphate solution and (B) outer surface and cross-sections of
SGMS and PGMS at day 21 post immersion in 0.02 M K2HPO4 solution, shown as an evidence.
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advantages of their spherical shape and porosity favouring
tissue ingrowth, revealing enhanced pro-osteogenic properties
provided by the HA conversion, and thus represent a promis-
ing novel material for bone repair applications.
To summarise overall, the novel rapid manufacturing
process to produce highly porous glass materials, contributed
towards rapid conversion of borate glasses to HA, which led to
the development of unique porous HA microspheres from
45B5, B53P4 and 13-93B, with external pores large enough to
support human stem cell incorporation.
6. Conclusions
Solid and porous glass microspheres from three different
borate glasses (i.e. 45B5, B53P4 and 13-93B) were successfully
manufactured into highly porous microspheres (porosity of
65–75% with pore size of 43–52 µm) via a flame spheroidisa-
tion process and their conversion to HA at different concen-
trations (i.e. 0.02 and 0.2 M) and media (i.e. K2HPO4, Na2HPO4
and SBF) were investigated. In addition, a cell culture study
was conducted to compare the influence of Boron containing
microspheres versus the HA converted microspheres.
PGMS (with the exception of 13-93B glass) revealed com-
plete conversion to HA and at much earlier timeframe in 0.02
M K2HPO4 solution compared to their SGMS counterparts, due
to their higher surface area. The conversion rates also
increased with increasing concentration of K2HPO4 solution.
However, 13-93B microspheres only revealed conversion to HA
in Na2HPO4 solution which was suggested to be due to the
presence of K in both the glass formulation and immersion
medium, inhibiting the ion exchange reaction. Borate glass
microspheres (both SGMS and PGMS) of all compositions
showed bioactivity in SBF and formation of HA was observed at
much earlier for PGMS compared to SGMS. Interestingly, both
SGMS and PGMS revealed full conversion to HA in SBF in com-
parison to 0.02 M K2HPO4 due to the presence of TRIS buffer
which accelerated their conversion rate. Moreover, converted
porous HA microspheres revealed enhanced pro-osteogenic
properties compared to their unconverted counterparts.
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